Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Van K Morris

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Advances in Radiation Oncology|February 3, 2026
Sexual Toxicity After Chemoradiation for Anal Cancer Among Men Who Have Sex With Men: A Mixed-Methods AnalysisBeck O Gold, Angie Arzola, Benjamin R Schrank, et al.
JCO Oncology Practice|May 26, 2023
Association of Emotional Exhaustion With Career Burnout Among Early-Career Medical Oncologists: A Single-Institution StudyAnmol P Singh, Lianchun Xiao, Barbara J O'Brien, et al.
JCO Oncology Practice|May 30, 2025
Erratum: Association of Emotional Exhaustion With Career Burnout Among Early-Career Medical Oncologists: A Single-Institution StudyAnmol P Singh, Lianchun Xiao, Barbara J O'Brien, et al.
The Oncologist|September 19, 2015
Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Asif Rashid, Miguel Rodriguez-Bigas, et al.
Future Oncology (London, England)|October 10, 2023
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR <i>BRAF</i>V600E-mutant mCRCElena Elez, Scott Kopetz, Josep Tabernero, et al.
Annals of Gastroenterology|January 2, 2020
Clinical characteristics of colitis induced by taxane-based chemotherapyEllie Chen, Hamzah Abu-Sbeih, Selvi Thirumurthi, et al.
Cancers|August 12, 2023
Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative ApproachJane E Rogers, Amanda Sirisaengtaksin, Michael Leung, et al.
Clinical Colorectal Cancer|July 19, 2020
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced HypersplenismAlexandre A Jácome, Aki Ohinata, Armeen Mahvash, et al.
Clinical Colorectal Cancer|January 12, 2024
Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality TherapyEthan P Damron, Jordan McDonald, Michael K Rooney, et al.
The Oncologist|April 27, 2023
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated CancersVan K Morris, Amir Jazaeri, Shannon N Westin, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Advances in Radiation Oncology|February 3, 2026
Sexual Toxicity After Chemoradiation for Anal Cancer Among Men Who Have Sex With Men: A Mixed-Methods AnalysisBeck O Gold, Angie Arzola, Benjamin R Schrank, et al.
JCO Oncology Practice|May 26, 2023
Association of Emotional Exhaustion With Career Burnout Among Early-Career Medical Oncologists: A Single-Institution StudyAnmol P Singh, Lianchun Xiao, Barbara J O'Brien, et al.
JCO Oncology Practice|May 30, 2025
Erratum: Association of Emotional Exhaustion With Career Burnout Among Early-Career Medical Oncologists: A Single-Institution StudyAnmol P Singh, Lianchun Xiao, Barbara J O'Brien, et al.
The Oncologist|September 19, 2015
Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Asif Rashid, Miguel Rodriguez-Bigas, et al.
Future Oncology (London, England)|October 10, 2023
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR <i>BRAF</i>V600E-mutant mCRCElena Elez, Scott Kopetz, Josep Tabernero, et al.
Annals of Gastroenterology|January 2, 2020
Clinical characteristics of colitis induced by taxane-based chemotherapyEllie Chen, Hamzah Abu-Sbeih, Selvi Thirumurthi, et al.
Cancers|August 12, 2023
Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative ApproachJane E Rogers, Amanda Sirisaengtaksin, Michael Leung, et al.
Clinical Colorectal Cancer|July 19, 2020
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced HypersplenismAlexandre A Jácome, Aki Ohinata, Armeen Mahvash, et al.
Clinical Colorectal Cancer|January 12, 2024
Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality TherapyEthan P Damron, Jordan McDonald, Michael K Rooney, et al.
The Oncologist|April 27, 2023
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated CancersVan K Morris, Amir Jazaeri, Shannon N Westin, et al.
Pageof 10